The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Allogeneic Stem Cell Therapy Market Research Report 2025
Synopsis
The global Allogeneic Stem Cell Therapy market was valued at US$ 757.3 million in 2023 and is anticipated to reach US$ 1499.5 million by 2030, witnessing a CAGR of 10.4% during the forecast period 2024-2030.
North American market for Allogeneic Stem Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Allogeneic Stem Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Allogeneic Stem Cell Therapy in Musculoskeletal Disorder is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Allogeneic Stem Cell Therapy include Escape Therapeutics, Inc., Lonza Group Ltd., Osiris Therapeutics (Smith & Nephew), NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Anterogen and MolMed S.p.A., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Allogeneic Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allogeneic Stem Cell Therapy.
Report Scope
The Allogeneic Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allogeneic Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allogeneic Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Escape Therapeutics, Inc.
Lonza Group Ltd.
Osiris Therapeutics (Smith & Nephew)
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Anterogen
MolMed S.p.A.
Takeda (TiGenix)
Segment by Type
Adult Stem Cell Therapy
Human Embryonic Stem Cell Therapy
Induced Pluripotent Stem Cell Therapy
Others
Segment by Application
Musculoskeletal Disorder
Wounds & Injuries
Cardiovascular Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allogeneic Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Allogeneic Stem Cell Therapy market was valued at US$ 757.3 million in 2023 and is anticipated to reach US$ 1499.5 million by 2030, witnessing a CAGR of 10.4% during the forecast period 2024-2030.
North American market for Allogeneic Stem Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Allogeneic Stem Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Allogeneic Stem Cell Therapy in Musculoskeletal Disorder is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Allogeneic Stem Cell Therapy include Escape Therapeutics, Inc., Lonza Group Ltd., Osiris Therapeutics (Smith & Nephew), NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Anterogen and MolMed S.p.A., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Allogeneic Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allogeneic Stem Cell Therapy.
Report Scope
The Allogeneic Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allogeneic Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allogeneic Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Escape Therapeutics, Inc.
Lonza Group Ltd.
Osiris Therapeutics (Smith & Nephew)
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Anterogen
MolMed S.p.A.
Takeda (TiGenix)
Segment by Type
Adult Stem Cell Therapy
Human Embryonic Stem Cell Therapy
Induced Pluripotent Stem Cell Therapy
Others
Segment by Application
Musculoskeletal Disorder
Wounds & Injuries
Cardiovascular Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allogeneic Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allogeneic Stem Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Adult Stem Cell Therapy
1.2.3 Human Embryonic Stem Cell Therapy
1.2.4 Induced Pluripotent Stem Cell Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Allogeneic Stem Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Musculoskeletal Disorder
1.3.3 Wounds & Injuries
1.3.4 Cardiovascular Diseases
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allogeneic Stem Cell Therapy Market Perspective (2019-2030)
2.2 Allogeneic Stem Cell Therapy Growth Trends by Region
2.2.1 Global Allogeneic Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Allogeneic Stem Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Allogeneic Stem Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Allogeneic Stem Cell Therapy Market Dynamics
2.3.1 Allogeneic Stem Cell Therapy Industry Trends
2.3.2 Allogeneic Stem Cell Therapy Market Drivers
2.3.3 Allogeneic Stem Cell Therapy Market Challenges
2.3.4 Allogeneic Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allogeneic Stem Cell Therapy Players by Revenue
3.1.1 Global Top Allogeneic Stem Cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Allogeneic Stem Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Allogeneic Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Allogeneic Stem Cell Therapy Revenue
3.4 Global Allogeneic Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Allogeneic Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allogeneic Stem Cell Therapy Revenue in 2023
3.5 Allogeneic Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Allogeneic Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Allogeneic Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Allogeneic Stem Cell Therapy Breakdown Data by Type
4.1 Global Allogeneic Stem Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Allogeneic Stem Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Allogeneic Stem Cell Therapy Breakdown Data by Application
5.1 Global Allogeneic Stem Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Allogeneic Stem Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Allogeneic Stem Cell Therapy Market Size (2019-2030)
6.2 North America Allogeneic Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Allogeneic Stem Cell Therapy Market Size by Country (2019-2024)
6.4 North America Allogeneic Stem Cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allogeneic Stem Cell Therapy Market Size (2019-2030)
7.2 Europe Allogeneic Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Allogeneic Stem Cell Therapy Market Size by Country (2019-2024)
7.4 Europe Allogeneic Stem Cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allogeneic Stem Cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Allogeneic Stem Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allogeneic Stem Cell Therapy Market Size (2019-2030)
9.2 Latin America Allogeneic Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Allogeneic Stem Cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Allogeneic Stem Cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allogeneic Stem Cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Allogeneic Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Escape Therapeutics, Inc.
11.1.1 Escape Therapeutics, Inc. Company Detail
11.1.2 Escape Therapeutics, Inc. Business Overview
11.1.3 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Introduction
11.1.4 Escape Therapeutics, Inc. Revenue in Allogeneic Stem Cell Therapy Business (2019-2024)
11.1.5 Escape Therapeutics, Inc. Recent Development
11.2 Lonza Group Ltd.
11.2.1 Lonza Group Ltd. Company Detail
11.2.2 Lonza Group Ltd. Business Overview
11.2.3 Lonza Group Ltd. Allogeneic Stem Cell Therapy Introduction
11.2.4 Lonza Group Ltd. Revenue in Allogeneic Stem Cell Therapy Business (2019-2024)
11.2.5 Lonza Group Ltd. Recent Development
11.3 Osiris Therapeutics (Smith & Nephew)
11.3.1 Osiris Therapeutics (Smith & Nephew) Company Detail
11.3.2 Osiris Therapeutics (Smith & Nephew) Business Overview
11.3.3 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Introduction
11.3.4 Osiris Therapeutics (Smith & Nephew) Revenue in Allogeneic Stem Cell Therapy Business (2019-2024)
11.3.5 Osiris Therapeutics (Smith & Nephew) Recent Development
11.4 NuVasive
11.4.1 NuVasive Company Detail
11.4.2 NuVasive Business Overview
11.4.3 NuVasive Allogeneic Stem Cell Therapy Introduction
11.4.4 NuVasive Revenue in Allogeneic Stem Cell Therapy Business (2019-2024)
11.4.5 NuVasive Recent Development
11.5 Chiesi Pharmaceuticals
11.5.1 Chiesi Pharmaceuticals Company Detail
11.5.2 Chiesi Pharmaceuticals Business Overview
11.5.3 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Introduction
11.5.4 Chiesi Pharmaceuticals Revenue in Allogeneic Stem Cell Therapy Business (2019-2024)
11.5.5 Chiesi Pharmaceuticals Recent Development
11.6 JCR Pharmaceutical
11.6.1 JCR Pharmaceutical Company Detail
11.6.2 JCR Pharmaceutical Business Overview
11.6.3 JCR Pharmaceutical Allogeneic Stem Cell Therapy Introduction
11.6.4 JCR Pharmaceutical Revenue in Allogeneic Stem Cell Therapy Business (2019-2024)
11.6.5 JCR Pharmaceutical Recent Development
11.7 Pharmicell
11.7.1 Pharmicell Company Detail
11.7.2 Pharmicell Business Overview
11.7.3 Pharmicell Allogeneic Stem Cell Therapy Introduction
11.7.4 Pharmicell Revenue in Allogeneic Stem Cell Therapy Business (2019-2024)
11.7.5 Pharmicell Recent Development
11.8 Anterogen
11.8.1 Anterogen Company Detail
11.8.2 Anterogen Business Overview
11.8.3 Anterogen Allogeneic Stem Cell Therapy Introduction
11.8.4 Anterogen Revenue in Allogeneic Stem Cell Therapy Business (2019-2024)
11.8.5 Anterogen Recent Development
11.9 MolMed S.p.A.
11.9.1 MolMed S.p.A. Company Detail
11.9.2 MolMed S.p.A. Business Overview
11.9.3 MolMed S.p.A. Allogeneic Stem Cell Therapy Introduction
11.9.4 MolMed S.p.A. Revenue in Allogeneic Stem Cell Therapy Business (2019-2024)
11.9.5 MolMed S.p.A. Recent Development
11.10 Takeda (TiGenix)
11.10.1 Takeda (TiGenix) Company Detail
11.10.2 Takeda (TiGenix) Business Overview
11.10.3 Takeda (TiGenix) Allogeneic Stem Cell Therapy Introduction
11.10.4 Takeda (TiGenix) Revenue in Allogeneic Stem Cell Therapy Business (2019-2024)
11.10.5 Takeda (TiGenix) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Allogeneic Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Adult Stem Cell Therapy
Table 3. Key Players of Human Embryonic Stem Cell Therapy
Table 4. Key Players of Induced Pluripotent Stem Cell Therapy
Table 5. Key Players of Others
Table 6. Global Allogeneic Stem Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Allogeneic Stem Cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Allogeneic Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Allogeneic Stem Cell Therapy Market Share by Region (2019-2024)
Table 10. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Allogeneic Stem Cell Therapy Market Share by Region (2025-2030)
Table 12. Allogeneic Stem Cell Therapy Market Trends
Table 13. Allogeneic Stem Cell Therapy Market Drivers
Table 14. Allogeneic Stem Cell Therapy Market Challenges
Table 15. Allogeneic Stem Cell Therapy Market Restraints
Table 16. Global Allogeneic Stem Cell Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Allogeneic Stem Cell Therapy Market Share by Players (2019-2024)
Table 18. Global Top Allogeneic Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Therapy as of 2023)
Table 19. Ranking of Global Top Allogeneic Stem Cell Therapy Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Allogeneic Stem Cell Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Allogeneic Stem Cell Therapy Product Solution and Service
Table 23. Date of Enter into Allogeneic Stem Cell Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Allogeneic Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2019-2024)
Table 27. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2025-2030)
Table 29. Global Allogeneic Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Allogeneic Stem Cell Therapy Revenue Market Share by Application (2019-2024)
Table 31. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Allogeneic Stem Cell Therapy Revenue Market Share by Application (2025-2030)
Table 33. North America Allogeneic Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Allogeneic Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Allogeneic Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Allogeneic Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Allogeneic Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Allogeneic Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Allogeneic Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Allogeneic Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Allogeneic Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Allogeneic Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Allogeneic Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 48. Escape Therapeutics, Inc. Company Detail
Table 49. Escape Therapeutics, Inc. Business Overview
Table 50. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product
Table 51. Escape Therapeutics, Inc. Revenue in Allogeneic Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 52. Escape Therapeutics, Inc. Recent Development
Table 53. Lonza Group Ltd. Company Detail
Table 54. Lonza Group Ltd. Business Overview
Table 55. Lonza Group Ltd. Allogeneic Stem Cell Therapy Product
Table 56. Lonza Group Ltd. Revenue in Allogeneic Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 57. Lonza Group Ltd. Recent Development
Table 58. Osiris Therapeutics (Smith & Nephew) Company Detail
Table 59. Osiris Therapeutics (Smith & Nephew) Business Overview
Table 60. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Product
Table 61. Osiris Therapeutics (Smith & Nephew) Revenue in Allogeneic Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 62. Osiris Therapeutics (Smith & Nephew) Recent Development
Table 63. NuVasive Company Detail
Table 64. NuVasive Business Overview
Table 65. NuVasive Allogeneic Stem Cell Therapy Product
Table 66. NuVasive Revenue in Allogeneic Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 67. NuVasive Recent Development
Table 68. Chiesi Pharmaceuticals Company Detail
Table 69. Chiesi Pharmaceuticals Business Overview
Table 70. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product
Table 71. Chiesi Pharmaceuticals Revenue in Allogeneic Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 72. Chiesi Pharmaceuticals Recent Development
Table 73. JCR Pharmaceutical Company Detail
Table 74. JCR Pharmaceutical Business Overview
Table 75. JCR Pharmaceutical Allogeneic Stem Cell Therapy Product
Table 76. JCR Pharmaceutical Revenue in Allogeneic Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 77. JCR Pharmaceutical Recent Development
Table 78. Pharmicell Company Detail
Table 79. Pharmicell Business Overview
Table 80. Pharmicell Allogeneic Stem Cell Therapy Product
Table 81. Pharmicell Revenue in Allogeneic Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 82. Pharmicell Recent Development
Table 83. Anterogen Company Detail
Table 84. Anterogen Business Overview
Table 85. Anterogen Allogeneic Stem Cell Therapy Product
Table 86. Anterogen Revenue in Allogeneic Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 87. Anterogen Recent Development
Table 88. MolMed S.p.A. Company Detail
Table 89. MolMed S.p.A. Business Overview
Table 90. MolMed S.p.A. Allogeneic Stem Cell Therapy Product
Table 91. MolMed S.p.A. Revenue in Allogeneic Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 92. MolMed S.p.A. Recent Development
Table 93. Takeda (TiGenix) Company Detail
Table 94. Takeda (TiGenix) Business Overview
Table 95. Takeda (TiGenix) Allogeneic Stem Cell Therapy Product
Table 96. Takeda (TiGenix) Revenue in Allogeneic Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 97. Takeda (TiGenix) Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Allogeneic Stem Cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Allogeneic Stem Cell Therapy Market Share by Type: 2023 VS 2030
Figure 3. Adult Stem Cell Therapy Features
Figure 4. Human Embryonic Stem Cell Therapy Features
Figure 5. Induced Pluripotent Stem Cell Therapy Features
Figure 6. Others Features
Figure 7. Global Allogeneic Stem Cell Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Allogeneic Stem Cell Therapy Market Share by Application: 2023 VS 2030
Figure 9. Musculoskeletal Disorder Case Studies
Figure 10. Wounds & Injuries Case Studies
Figure 11. Cardiovascular Diseases Case Studies
Figure 12. Others Case Studies
Figure 13. Allogeneic Stem Cell Therapy Report Years Considered
Figure 14. Global Allogeneic Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Allogeneic Stem Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Allogeneic Stem Cell Therapy Market Share by Region: 2023 VS 2030
Figure 17. Global Allogeneic Stem Cell Therapy Market Share by Players in 2023
Figure 18. Global Top Allogeneic Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Therapy as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Allogeneic Stem Cell Therapy Revenue in 2023
Figure 20. North America Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Allogeneic Stem Cell Therapy Market Share by Country (2019-2030)
Figure 22. United States Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Allogeneic Stem Cell Therapy Market Share by Country (2019-2030)
Figure 26. Germany Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Allogeneic Stem Cell Therapy Market Share by Region (2019-2030)
Figure 34. China Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Allogeneic Stem Cell Therapy Market Share by Country (2019-2030)
Figure 42. Mexico Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Allogeneic Stem Cell Therapy Market Share by Country (2019-2030)
Figure 46. Turkey Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Allogeneic Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Escape Therapeutics, Inc. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2019-2024)
Figure 49. Lonza Group Ltd. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2019-2024)
Figure 50. Osiris Therapeutics (Smith & Nephew) Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2019-2024)
Figure 51. NuVasive Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2019-2024)
Figure 52. Chiesi Pharmaceuticals Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2019-2024)
Figure 53. JCR Pharmaceutical Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2019-2024)
Figure 54. Pharmicell Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2019-2024)
Figure 55. Anterogen Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2019-2024)
Figure 56. MolMed S.p.A. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2019-2024)
Figure 57. Takeda (TiGenix) Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
